Literature DB >> 346288

Individual differences in the disposition of drugs metabolised in the body.

G Alvan.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 346288     DOI： 10.2165/00003088-197803020-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  90 in total

1.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

2.  Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

Authors:  D Perrier; M Gibaldi
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

3.  Abnormal pharmacokinetics of phenytoin in a patient with uraemia.

Authors:  I Odar-Cederlöf; P Lunde; F Sjöqvist
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

4.  The absorption of orally administered (12 - 3 H)digoxin in man.

Authors:  B Beermann; K Hellström; A Rosén
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Fate of orally administered 3H-digitoxin in man with special reference to the absorption.

Authors:  B Beermann; K Hellström; A Rosén
Journal:  Circulation       Date:  1971-06       Impact factor: 29.690

7.  Enterohepatic circulation of indomethacin and its role in intestinal irritation.

Authors:  D E Duggan; K F Hooke; R M Noll; K C Kwan
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

8.  Pharmacokinetics of fluoride in man after single and multiple oral doses.

Authors:  J Ekstrand; G Alván; L O Boréus; A Norlin
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

9.  Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.

Authors:  K E Andersson; B Bergdahl; G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

10.  Tricyclic antidepressants. Prolonged plasma levels after overdose.

Authors:  D G Spiker; J T Biggs
Journal:  JAMA       Date:  1976-10-11       Impact factor: 56.272
View more
  20 in total

Review 1.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  Intra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200-mg tablets and 400-mg suspension.

Authors:  W K Cheung; F Kianifard; A Wong; J Mathieu; T Cook; V John; E Redalieu; K Chan
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--histograms and probit plots.

Authors:  P R Jackson; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

4.  Variability in biological monitoring of solvent exposure. I. Development of a population physiological model.

Authors:  P O Droz; M M Wu; W G Cumberland; M Berode
Journal:  Br J Ind Med       Date:  1989-07

5.  Bioavailability and pharmacokinetics of cimetidine.

Authors:  A Grahnén; C von Bahr; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

6.  Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.

Authors:  M Eichelbaum; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Interindividual variations in drug disposition. Clinical implications and methods of investigation.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

8.  Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.

Authors:  K Krishnaswamy; R Kalamegham; N A Naidu
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

9.  Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.

Authors:  M Jerling; Y Merlé; F Mentré; A Mallet
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

Review 10.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.